In a hepatocellular carcinoma, when originated by the infection of hepatitis B virus (HBV), Plk1 has been suggested to participate in the transformation event by modulating the degradation of two transcription repression factors, SUZ12 and ZNF198 [49] (Figure 1d). Here, SUZ12 is linked to hepatocellular carcinoma.